Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Viral Vector Production Market, by Type
1.4.2 North America Viral Vector Production Market, by Indication
1.4.3 North America Viral Vector Production Market, by Application
1.4.4 North America Viral Vector Production Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Viral Vector Production Market
Chapter 5. North America Viral Vector Production Market, by Type
5.1 North America Adeno-Associated Viral Vectors Market, by Country
5.2 North America Lentiviral Vectors Market, by Country
5.3 North America Adenoviral Vectors Market, by Country
5.4 North America Retroviral Vectors Market, by Country
5.5 North America Others Market, by Country
Chapter 6. North America Viral Vector Production Market, by Indication
6.1 North America Cancer Market, by Country
6.2 North America Genetic Disorders Market, by Country
6.3 North America Infectious Diseases Market, by Country
6.4 North America Others Market, by Country
Chapter 7. North America Viral Vector Production Market, by Application
7.1 North America Gene Therapy Market, by Country
7.2 North America Vaccinology Market, by Country
Chapter 8. North America Viral Vector Production Market, by Country
8.1 US Viral Vector Production Market
8.1.1 US Viral Vector Production Market, by Type
8.1.2 US Viral Vector Production Market, by Indication
8.1.3 US Viral Vector Production Market, by Application
8.2 Canada Viral Vector Production Market
8.2.1 Canada Viral Vector Production Market, by Type
8.2.2 Canada Viral Vector Production Market, by Indication
8.2.3 Canada Viral Vector Production Market, by Application
8.3 Mexico Viral Vector Production Market
8.3.1 Mexico Viral Vector Production Market, by Type
8.3.2 Mexico Viral Vector Production Market, by Indication
8.3.3 Mexico Viral Vector Production Market, by Application
8.4 Rest of North America Viral Vector Production Market
8.4.1 Rest of North America Viral Vector Production Market, by Type
8.4.2 Rest of North America Viral Vector Production Market, by Indication
8.4.3 Rest of North America Viral Vector Production Market, by Application
Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
Unique Offerings 